Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Clinical Pharmacology and Therapeutics
|
July 1, 1989
Disposition of perphenazine is related to polymorphic debrisoquin hydroxylation in human beings
M L Dahl-Puustinen, A Lidén, C Alm, et al.
Anesthesiology
|
January 7, 1998
Systemic absorption and block after epidural injection of ropivacaine in healthy volunteers
B M Emanuelsson, J Persson, C Alm, et al.
British Journal of Clinical Pharmacology
|
December 1, 1989
Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation
Q Y Yue, J O Svensson, C Alm, et al.
Nordisk Medicin
|
January 1, 1995
[Need for a long-term program in the follow-up of anti-lipid treatment following coronary artery surgery?]
B Israelsson, M Stagmo, C Alm, et al.
Lancet (London, England)
|
March 11, 1989
Debrisoquine hydroxylation polymorphism and personality
L Bertilsson, C Alm, C De Las Carreras, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1996
Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity
J A Carrillo, M L Dahl, J O Svensson, et al.
British Journal of Clinical Pharmacology
|
September 1, 1990
Lack of relationship between glibenclamide metabolism and debrisoquine or mephenytoin hydroxylation phenotypes
M L Dahl-Puustinen, C Alm, L Bertilsson, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1994
Stereoselective disposition of mianserin is related to debrisoquin hydroxylation polymorphism
M L Dahl, G Tybring, C E Elwin, et al.
Therapeutic Drug Monitoring
|
August 15, 2000
Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine
J A Carrillo, M Christensen, S I Ramos, et al.
The Journal of Endocrinology
|
March 19, 2013
Maternal perinatal diet induces developmental programming of bone architecture
M J Devlin, C Grasemann, A M Cloutier, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Clinical Pharmacology and Therapeutics
|
July 1, 1989
Disposition of perphenazine is related to polymorphic debrisoquin hydroxylation in human beings
M L Dahl-Puustinen, A Lidén, C Alm, et al.
Anesthesiology
|
January 7, 1998
Systemic absorption and block after epidural injection of ropivacaine in healthy volunteers
B M Emanuelsson, J Persson, C Alm, et al.
British Journal of Clinical Pharmacology
|
December 1, 1989
Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation
Q Y Yue, J O Svensson, C Alm, et al.
Nordisk Medicin
|
January 1, 1995
[Need for a long-term program in the follow-up of anti-lipid treatment following coronary artery surgery?]
B Israelsson, M Stagmo, C Alm, et al.
Lancet (London, England)
|
March 11, 1989
Debrisoquine hydroxylation polymorphism and personality
L Bertilsson, C Alm, C De Las Carreras, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1996
Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity
J A Carrillo, M L Dahl, J O Svensson, et al.
British Journal of Clinical Pharmacology
|
September 1, 1990
Lack of relationship between glibenclamide metabolism and debrisoquine or mephenytoin hydroxylation phenotypes
M L Dahl-Puustinen, C Alm, L Bertilsson, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1994
Stereoselective disposition of mianserin is related to debrisoquin hydroxylation polymorphism
M L Dahl, G Tybring, C E Elwin, et al.
Therapeutic Drug Monitoring
|
August 15, 2000
Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine
J A Carrillo, M Christensen, S I Ramos, et al.
The Journal of Endocrinology
|
March 19, 2013
Maternal perinatal diet induces developmental programming of bone architecture
M J Devlin, C Grasemann, A M Cloutier, et al.
Page
of 4